Diabetes and Pregnancy
Also known as: Gestational diabetes, Diabetes - gestational, Diabetes, Diabetic
Methodology & AI Transparency ⓘ
Diabetes and Pregnancy Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What is diabetes? If you have diabetes , your blood glucose , or blood sugar, levels are too high.
- 2 Real-world patient consensus: Synonyms for Diabetes and Pregnancy (O24.419): Gestational diabetes, Diabetes - gestational, Diabetes (Fertility & Pregnancy).
- 3 Typical cash cost range: Differential triage of Diabetes and Pregnancy (O24.419) utilizes close prenatal blood in Diabetes and Pregnancy (O24.419: pressure).
- 4 Top reported side effects / signs: Follow-up benchmark in Diabetes and Pregnancy: maintaining Anti-Mullerian Hormone (AMH) in Diabetes and Pregnancy (O24.419: & Day-3 FSH) within Age-contextual ovarian reserve (O24.419).
Ask our AI Specialists anything about Diabetes and Pregnancy
What Is Diabetes and Pregnancy?
What is diabetes? If you have diabetes , your blood glucose , or blood sugar, levels are too high. Glucose comes from the foods you eat. A hormone called insulin helps the glucose get into your cells to give them energy. With type 1 diabetes , your body does not make insulin. With type 2 diabetes , your body does not make or use insulin well. Without enough insulin, the glucose stays in your blood. What is gestational diabetes? Some people already have diabetes before they get pregnant. But others may develop diabetes during pregnancy. This type of diabetes is called gestational diabetes. It usually develops around the 24th week of pregnancy.
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in Diabetes and Pregnancy (O24.419) features ovulatory hypothalamic-pituitary-gonadal axis in Diabetes and Pregnancy (O24.419: disruption). Cross-referenced with NIH MeSH (Pregnancy in Diabetics), therapeutic stabilization in fertility & pregnancy is verified against Maternal Blood Pressure in Diabetes and Pregnancy (O24.419: & Urine Protein).
Common Symptoms & Clinical Signs
- • Are overweight or have obesity
- • Have a family history of diabetes
- • Presentation of Diabetes and Pregnancy (O24.419): inability to achieve in Diabetes and Pregnancy (O24.419: clinical pregnancy after)
- • Secondary Diabetes and Pregnancy clinical sign: irregular luteal phase in Diabetes and Pregnancy (O24.419: timing, anovulatory cycles,)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Diabetes and Pregnancy Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | O24.419 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Fertility, Pregnancy & Postpartum Care | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Anti-Mullerian Hormone (AMH) in Diabetes and Pregnancy (O24.419: & Day-3 FSH) | Age-contextual ovarian reserve (O24.419) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Maternal Blood Pressure in Diabetes and Pregnancy (O24.419: & Urine Protein) | BP < 120/80 mmHg; negative proteinuria (O24.419) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Prenatal TSH, Ferritin in Diabetes and Pregnancy (O24.419: & Glucose Screen) | Trimester-specific clinical range (O24.419) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Diabetes and Pregnancy
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Norethindrone Errin, Incassia • RxCUI 198042 | Progestin | 77% | $0.0849 | $ 6.46 /mo |
| Levonorgestrel and Ethinyl Estradiol Vienva Tm, Altavera • RxCUI 722152 | Progestin | 93% | $0.1509 | $ 8.73 /mo |
| Norelgestromin and Ethinyl Estradiol Xulane, Zafemy • RxCUI 1534809 | Progestin | 86% | $31.3170 | $ 185.00 /mo |
| Tilia Fe (Ndac and Ee Tablets and Ferrous Fumarate Tablets) Tilia Fe • RxCUI 1359130 | FDA Prescription Therapeutic Agent | 88% | $0.7339 | $ 61.34 /mo |
| Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate Tablets Xarah Fe • RxCUI 259176 | FDA Prescription Therapeutic Agent | 78% | $0.7339 | $ 38.22 /mo |
| Copper Paragard T 380a, Cuprum Metallicum • RxCUI 2267305 | Copper-containing Intrauterine Device | 90% | $0.8800 | $ 44.14 /mo |
| Carboprost Tromethamine Hemabate • RxCUI 238014 | Prostaglandin Analog | 94% | $3.0900 | $ 133.64 /mo |
| Norethindrone and Ethinyl Estradiol Tablet Rhuzdah • RxCUI 238015 | FDA Prescription Therapeutic Agent | 94% | $0.0849 | $ 11.94 /mo |
| Norethindrone Acetate/Ethinyl Estradiol Larin 1.5/30, Microgestin 1.5/30 • RxCUI 1359022 | Birth Control Agent | 84% | $0.3169 | $ 7.17 /mo |
| Hemabate (Carboprost Tromethamine) Hemabate • RxCUI RXN-B00090856 | Prostaglandin Analog | 85% | $3.0800 | $ 230.26 /mo |
| Levonorgestrel Tablet, 1.5 Mg Optionelle • RxCUI 483325 | Progestin | 83% | $6.6295 | $ 185.00 /mo |
| Rhuzdah (Norethindrone and Ethinyl Estradiol Tablet) Rhuzdah • RxCUI 749736 | FDA Prescription Therapeutic Agent | 81% | $0.0849 | $ 14.61 /mo |
| Follitropin Gonal-F Rff Redi-Ject, Follistim Aq • RxCUI 1594334 | Gonadotropin | 93% | $1.5900 | $ 72.90 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Diabetes and Pregnancy)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Benefits and safety of empagliflozin as add-on to metformin for type 2: What a 4,256-Participant Study Found EMPA as add-on to MET was well tolerated and provided additional benefits beyond glucose lowering, such as weight loss and blood pressure reduction. European journal of clinical pharmacology • 2016-06-15 • Meta-Analysis | N = 4,256 | 99/100 | PMID 26832915 ↗ |
| New Insights on Is metformin still the most efficacious first-line oral hypoglycaemic drug in: What a 33,830-Participant Study Found This meta-analysis showed that repaglinide and metformin would be the most efficacious oral drugs for first-line single-drug treatment of T2DM. Obesity reviews : an official journal of the International Association for the Study of Obesity • 2019-01-15 • Meta-Analysis | N = 33,830 | 99/100 | PMID 30230172 ↗ |
| New Insights on Heart and blood vessel outcomes of liraglutide in patients with type 2: What a 14,608-Participant Study Found Our results suggest that liraglutide treatment decreases the risk of MACE, AMI, all-cause death and heart and blood vessel death among patients with type 2 diabetes. Medicine • 2019-11-15 • Meta-Analysis | N = 14,608 | 99/100 | PMID 31725627 ↗ |
| New Insights on Urinary tract infections in patients with diabetes treated with: What a 3,152-Participant Study Found Treatment of type 2 diabetes with once-daily dapagliflozin 5 or 10mg is accompanied by a slightly increased risk of urinary tract infection. Journal of diabetes and its complications • 2013-01-15 • Meta-Analysis | N = 3,152 | 99/100 | PMID 23849632 ↗ |
| New Insights on Effect of metformin on microvascular outcomes in patients with type 2: What a 18,181-Participant Study Found There is no evidence of clinically significant beneficial effect of metformin therapy as compared to other glucose-lowering medications or placebo on the examined microvascular complications. Diabetes research and clinical practice • 2022-04-15 • Meta-Analysis | N = 18,181 | 99/100 | PMID 35247521 ↗ |
Diabetes and Pregnancy Patient Community & “People Like Me” Threads
Filter Diabetes and Pregnancy community threads and patient logs by age, biological sex, dosage, and treatment duration.